Overview

A Study in Healthy Young Men to Look at What Drives the Cardiovascular Effects After Dosing With Mirabegron.

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
To explore what is driving heart-rate increases after dosing with mirabegron. Subjects will be given a beta-blocker at the same time as mirabegron.
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Bisoprolol
Mirabegron
Propranolol